This inventor holds 2 USPTO granted patents. Top assignee: Keystone Biomedical, Inc.. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: James P. Hudspeth: Innovator in Chemical Synthesis
Introduction
James P. Hudspeth is a notable inventor based in Santa Rosa, California. He has made significant contributions to the field of chemical synthesis, particularly in developing innovative iron-binding compounds known as Exochelins. His research aims to enhance the physiological properties of these compounds for various medical applications, including diagnosing and treating diseases in mammals.
Latest Patents
Hudspeth holds two patents, with the latest focusing on the chemical synthesis of Exochelins. This patent outlines a process for the synthetic generation of high-affinity, iron-binding compounds. The innovations described in this patent include modifications to the synthesized compounds to vary their physiological properties, showcasing their potential utility in medical applications.
Career Highlights
Currently, James P. Hudspeth is affiliated with Keystone Biomedical, Inc. His career reflects a strong commitment to advancing the field of biomedical research through innovative chemical processes. His work has positioned him as a relevant figure in the realm of synthetic chemistry and its applications in medicine.
Collaborations
Throughout his career, Hudspeth has collaborated with notable colleagues, including Leo S. Geraci and Stuart G. Levy. These collaborations have facilitated the exchange of ideas and innovations, further enriching the research landscape in which he operates.
Conclusion
James P. Hudspeth exemplifies the role of an inventor dedicated to advancing science and medicine through innovative chemical synthesis. His work on Exochelins not only demonstrates his creativity as an inventor but also his commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile